Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein
Alume Biosciences has received Breakthrough Therapy Designation (BTD) from the US Food and Drug Administration (FDA) for bevonescein, an investigational fluorescent drug being developed to support real-time nerve visualisation during head and neck surgery in adults. Bevonescein is an intravenous fluorescent peptide-dye conjugate that binds to nerve tissue....
USF Researchers Identify New P. vivax Vaccine Target
Researchers at USF Health have identified a previously unknown vulnerability in Plasmodium vivax, a major malaria parasite found across parts of Asia and Central and South America....
Nuvectis’ NXP200 Receives Breakthrough Designation for Glioma
Nuvectis Pharma has announced that China’s Center for Drug Evaluation (CDE) has granted Breakthrough Therapy Designation (BTD) to NXP200 (HSK42360) for patients with BRAF V600-mutant, recurrent or progressive high-grade glioma....
UGA researchers develop oral drug candidate targeting drug-resistant malaria
Researchers from the University of Georgia (UGA) and the University of Illinois Chicago have developed a new oral antimalarial drug candidate that could help address drug-resistant malaria....
Revolution Medicines gains FDA Breakthrough Therapy status for RASONQUE
Revolution Medicines has received Breakthrough Therapy Designation from the US Food and Drug Administration (FDA) for RASONQUE (daraxonrasib) in previously untreated metastatic pancreatic ductal adenocarcinoma (PDAC)....
Juniper Biosciences Secures FDA Breakthrough Designation
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Juniper Biosciences’ JBS-003 (18F-fluoromisonidazole, or FMISO) for identifying tumour hypoxia in patients with HPV-positive oropharyngeal carcinoma (OPC)....
University of Toronto Advances tRNA Therapy for Genetic Diseases
Researchers at the University of Toronto have developed an engineered transfer RNA (tRNA) approach that could support the treatment of multiple genetic diseases caused by the same type of mutation....
University of Dundee’s Cabamiquine Shows Promise for Single-Dose Malaria Treatment
Researchers at the University of Dundee have reported encouraging clinical results for cabamiquine, a novel antimalarial compound being developed as a potential single-dose treatment for malaria....
NORROY’s 68Ga-NYM096 Receives FDA Breakthrough Therapy and Fast Track Designations
Norroy bioscience, a clinical-stage biotechnology company focused on targeted radiopharmaceuticals, has announced that the US Food and Drug Administration (FDA) has granted Breakthrough...
RiboX Wins FDA IND Clearance for circRNA CAR-T Therapy
RiboX Therapeutics has received U.S. Food and Drug Administration (FDA) clearance for the Investigational New Drug (IND) application for RXIM002, an investigational circular RNA (circRNA)-based in vivo CAR-T therapy....
